Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2012-06-25

FDA Approved: TRI-LO-MARZIA — Original Application (Lupin Pharmaceuticals, Inc.)

View source ↗

Summary

FDA approved Lupin Pharmaceuticals' Tri-Lo-Marzia as an original-application generic oral contraceptive containing norgestimate and ethinyl estradiol.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • TRI-LO-MARZIA (NORGESTIMATE AND ETHINYL ESTRADIOL)

Snippet

ORIG AP for TRI-LO-MARZIA (NORGESTIMATE AND ETHINYL ESTRADIOL)